fbpx
FDR Station, PO Box 220
New York, NY 10150
1-800-ALZINFO (259-4636)
Phone: 1-212-915-1328
Email: info@alzinfo.org
CLOSE X
alzheimer's causes
Understanding Alzheimer’s DiseaseTop Ten Signs of Alzheimer’sAlzheimer’s Disease Facts and StatisticsDementia vs Alzheimer’sSenile DementiaClinical Stages of Alzheimer’sClinical Trials FAQsClinical Trials
alzheimer's care
CaregivingCaregiver’s CornerTherapeutic ActivitiesTips for the Caregivers from DoctorsDiet, Exercise & HealthCaregivers in TrainingHome ModificationContinuing CareBereavement and GriefLegal & Financial Planning
alzheimer's cure
Alzheimer’s ResearchAbout Our ResearchOur Research TeamProgress ReportsExplore Alzheimer’s Research
About Fisher Center FoundationAlzheimer’s NewsVideosResource LocatorMemory WallPreserving Your Memory® MagazineAsk The Experts
Copyright © 2021 The Fisher Center for Alzheimer's Research Foundation, a 501c3 not for profit,Tax ID # 13-3859563

LATEST ALZHEIMER'S RESEARCH NEWS YOU CAN USE

Expert reviewed Alzheimer’s and Dementia News

Category: Drugs and Treatment

Drugmaker Eli Lilly to Seek Approval for New Alzheimer’s Drug, Donanemab
July 13, 2021
The drugmaker Eli Lilly announced that it will seek fast approval from the Food and Drug Administration for a new…
Learn More
Alzheimer's drug Aduhelm
What You Need to Know About the New Alzheimer’s Drug Aduhelm
July 13, 2021
In June, the Food and Drug Administration approved the new drug Aduhelm for people with Alzheimer’s disease. It was the…
Learn More
FDA Approves First New Alzheimer’s Drug in 18 Years
June 8, 2021
The Food and Drug Administration approved the first new Alzheimer’s drug in nearly two decades. The drug, called aducanumab, will…
Learn More
Experimental Drug, Donanemab, Shows Promise in Slowing Alzheimer’s
January 5, 2021
An experimental drug called donanemab showed promise in slowing the decline of Alzheimer’s disease in a medium-size clinical trial. People…
Learn More
New Drug, Aducanumab, Fails to Advance in Expert Review
December 10, 2020
A panel of medical experts recommended strongly against approval for a new drug for Alzheimer’s disease that is up for…
Learn More
Three Fourths of Alzheimer’s Patients Are on Risky Medications
November 24, 2020
Nearly three quarters of people with Alzheimer’s disease or other forms of dementia are on medications that were not specifically…
Learn More
A Reminder to Keep Taking Your Blood Pressure Medications
June 19, 2020
Many people have been putting off doctor visits or prescription refills because of fears about visiting the doctor’s office or…
Learn More
Senior Man taking pills
Take Your Blood Pressure Meds. It May Reduce Your Alzheimer’s Risk.
January 15, 2020
Here’s another reason to take your blood pressure medications: Keeping your blood pressure in check in middle age may reduce…
Learn More
Drug Company to Pursue Approval of Aducanumab, New Drug for Alzheimer’s
January 15, 2020
The drug company Biogen is seeking approval for an experimental drug called aducanumab for treating people in the early stages…
Learn More
Drugs May Not Be the Best Choice for Easing the Agitation of Alzheimer’s
November 11, 2019
Massage, touch therapy, exercise, music therapy and other non-drug treatments can be an effective way to reduce aggression and agitation…
Learn More
Alzheimer’s Drug May Lead to Life-Threatening Muscle Disease
October 2, 2019
Many people with Alzheimer’s disease take the drug donepezil (brand name Aricept) to help ease symptoms for a time. But…
Learn More
Opiods Pain Killers Risk Alzheimer's
Opioid Painkillers Increase Pneumonia Risk in People With Alzheimer’s Disease
August 20, 2019
People with Alzheimer’s disease who are treated with opioid painkillers are at increased risk of developing pneumonia. The risk was…
Learn More
Drug Companies Halt Trials of Aducanumab for Alzheimer’s Disease
July 2, 2019
The drug makers Biogen and Eisai have decided to abandon late-stage testing of a promising new drug for Alzheimer’s disease,…
Learn More
Diabetes Treatments May Help Ward Off Alzheimer’s Disease
June 6, 2019
People with Type 2 diabetes should be treated promptly for their disease, which will not only help to manage their…
Learn More
Mushrooms Help Memory
Can Mushrooms Help Your Memory?
June 5, 2019
Eating mushrooms may be good for your brain. A study found that older men and women who ate mushrooms as…
Learn More
Buyer Beware: Dietary Supplement’s Won’t Cure Alzheimer’s Disease
February 28, 2019
The Food and Drug Administration is cracking down on makers of dietary supplements that claim to cure Alzheimer’s disease and…
Learn More
Experimental Drug, Fails to Benefit Alzheimer’s Patients
October 11, 2018
In a rigorous late-stage trial, an experimental drug called verubecestat failed to improve memory and thinking skills or slow the…
Learn More
New Drug Shows Promise for Alzheimer’s
September 18, 2018
A new drug showed promise in both reducing the plaques that build up in the brains of those with Alzheimer’s…
Learn More
Pain Relievers Present Special Hazards in People With Alzheimer’s Disease
September 5, 2018
People with Alzheimer’s disease and other forms of dementia were especially likely to suffer from harmful side effects from commonly…
Learn More
Care Management Program Is Reducing Need for Anti-anxiety Medication and Visits to the Hospital/Emergency Room
August 16, 2018
New York, NY, August 2018 – Last year researchers at the Zachary and Elizabeth M. Fisher Alzheimer Disease Education and…
Learn More
Music May Ease the Anxiety of Alzheimer’s
May 17, 2018
More good news on the music and Alzheimer’s front. Researchers report that music activates parts of the brain spared by…
Learn More
Experimental Alzheimer’s Drug, Intepirdine, Disappoints in Study
December 12, 2017
Late-stage trials of an experimental drug called intepirdine showed disappointing results in improving memory and thinking skills in people with…
Learn More
An Eye Scan for Alzheimer’s?
December 12, 2017
Researchers are getting closer to developing an eye scan to detect Alzheimer’s disease at its earliest stages, before symptoms become…
Learn More
Drug to treat Alzheimer’s is Ranked Highest
November 1, 2017
Aricept Ranks Highest Among Drugs to Treat Alzheimer’s A new analysis that looked at four drugs currently approved to treat…
Learn More
Next
WE CAN END ALZHEIMER'S

We support the pioneering research of the late Nobel Laureate Dr. Paul Greengard under the leadership of Dr. Marc Flajolet and his team as they continue pursuing the quest for a cure.

DONATE FOR THE CURE
We consistently receive top awards and ratings for our accountability:
Charity Navigator
GuideStar Gold Seal of Transparency
America's Best Charities
Combined Federal Campaign
Health and Medical Research Charities of America
National Health Information Awards

Connect with Us

Mailing Address:
The Fisher Center for Alzheimer's Research Foundation
FDR Station, PO Box 220
New York, NY 10150

1-800-ALZINFO (259-4636)
Phone: 1-212-915-1328
Email: info@alzinfo.org

Top Links

Understanding Alzheimer’s DiseaseAlzheimer's DiagnosisDementia vs. Alzheimer'sTop Ten Signs of Alzheimer'sClinical Stages of Alzheimer’s

About Fisher

About UsFinancialsTerms of ServicePrivacy Policy501 C 3 Letter

Information Program

Alzheimer’s NewsPreserving Your Memory® MagazineResource LocatorCaregiver’s CornerVideos
Copyright © 2021 The Fisher Center for Alzheimer's Research Foundation, a 501c3 not for profit,Tax ID # 13-3859563